Feasibility and safety of Sapien 3 TAVR in intermediate-risk patients

Autor:	Bahaa Alhabil, Alain Dibie, Christophe Caussin
Rok vydání:	2017
Předmět:	medicine.medical_specialty business.industry Emergency medicine medicine Cardiology and Cardiovascular Medicine Intermediate risk business
Zdroj:	Archives of Cardiovascular Diseases Supplements. 9:60
ISSN:	1878-6480
DOI:	10.1016/s1878-6480(17)30192-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7b19267764e3b7fdc61f59b614a15316 https://doi.org/10.1016/s1878-6480(17)30192-1 Zobrazit plný text záznamu Full Text from ScienceDirect